bevacizumab
UkraineDrugs containing this active substance
-
The drug is used to treat various types of cancer, including metastatic colorectal cancer, breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial cancer of the ovaries and fallopian tubes, primary peritoneal cancer, cervical cancer, and recurrent glioblastoma.
Form: concentrate for infusion solution
Active substance Dosage bevacizumab 25 mg/ml ATC: L01FG01
-
The drug is prescribed for the treatment of various types of cancer, including metastatic colorectal cancer, non-small cell lung cancer, recurrent glioblastoma, renal cell carcinoma, cervical cancer, and metastatic breast cancer.
Form: concentrate for infusion solution
Active substance Dosage bevacizumab 25 mg/ml ATC: L01FG01
Manufacturer: Dr. Reddy's Laboratories Ltd
-
The drug is prescribed for the treatment of metastatic colorectal cancer, metastatic breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial cancer of the ovaries and fallopian tubes, primary peritoneal cancer, as well as cervical cancer.
Form: concentrate for infusion solution
Active substance Dosage bevacizumab 25 mg/ml ATC: L01FG01